Profound Medical Reports Q3 Preliminary Revenue Range $9.8M - $10M, Up ~85% To 89% YoY

Profound Medical Corp. reported preliminary unaudited revenues for Q3 2026 in the range of $9.8 million to $10 million, reflecting a year-over-year growth of approximately 85% to 89% from $5.3 million in Q3 2025. Additionally, the company anticipates a sequential quarter-over-quarter growth of about 292% to 300% compared to $2.5 million in Q2 2026.